Electrophysiology Devices Market
Electrophysiology Devices Market Analysis by Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, and Access Devices from 2023 to 2033
Analysis of Electrophysiology Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Electrophysiology Devices Market Outlook (2022 to 2033)
Expanding at a high-value CAGR of 8.5%, the global electrophysiology devices market is expected to increase from a value of US$ 9.20 billion in 2023 to US$ 20.80 billion by 2033-end.
An electrophysiology (EP) test is a procedure that is used to evaluate the electrical activity or system of the heart and is used to identify irregular heartbeats or arrhythmias. To conduct the test, catheters are inserted into the blood arteries leading to the heart, followed by wire electrodes that measure electrical activity.
For electrophysiology, which is important for electrodiagnosis and monitoring, measures of the electrical activity of neurons are taken into account in neuroscience. With the substantial improvement in electrophysiology methods, it is now easier to target the heart conditions that cause atrial fibrillation (AF). Since cardiac arrhythmias affect half the population, electrophysiological equipment is used to identify them.
Electrophysiology devices are classified into electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology laboratory devices, and electrophysiology access devices. Global demand for electrophysiology ablation catheters is expected to increase at a high CAGR of 9.5% from 2023 to 2033.
Ablation is a procedure that restores the functionality of your heart by carefully removing any abnormal tissue. EP ablation is a minimally-invasive surgical procedure that employs catheters to close off the troublesome electrical pathways in the heart.
The apparatus helps remove aberrant heart tissues that lead to erratic heart rhythms. The most popular ablation catheter types are radiofrequency ablation and cryoablation, and both are anticipated to hold sizable market shares due to associated technological improvements.
- In the case of patients who have persistent atrial fibrillation (PeAF) and heart failure (HF), catheter ablation (CA) seems to enhance left ventricular function, according to a study published in 2022 with the title “Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study”.
- Out-of-hospital cardiac arrest (OHCA) affects more than 250,000 Americans annually, according to the Cardiac Arrest Registry to Enhance Survival (CARES) 2021 annual report. Cardiac electrophysiology devices are used more commonly as a result of their ubiquity, which accelerates their sales growth.
Factors anticipated to drive demand for molecular electrophysiology devices during the projected period include growing acceptance of electrophysiology devices in the diagnosis and treatment of cardiovascular illnesses such as atrial fibrillation and rising demand for devices for cardiac rhythm management for continuous monitoring.
Report Attributes |
Details |
|
Electrophysiology Devices Market Size (2023E) |
US$ 9.20 Billion |
|
Forecasted Market Value (2033F) |
US$ 20.80 Billion |
|
Global Market Growth Rate (2023 to 2033) |
8.5% CAGR |
|
China Market Growth Rate (2023 to 2033) |
8% CAGR |
|
Japan Market Growth Rate (2023 to 2033) |
8% CAGR |
|
Germany Market Growth Rate (2023 to 2033) |
7% CAGR |
|
Canada Market Growth Rate (2023 to 2033) |
7% CAGR |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Global Demand for Electrophysiology Devices Surging?
“Introduction of Interventional Cardiology Devices”
The high utilization rates of cardiac diagnostics and monitoring devices for arrhythmias and the growing popularity of ambulatory monitoring systems are boosting sales of diagnostic devices. Some of the EP diagnostic devices are Holter monitors, ECGs, mapping & imaging systems, diagnostic catheters, and implantable cardiac devices. The advent of portable & digital systems and the expanding use of these devices in interventional medical procedures such as catheter placement are fuelling demand for electrophysiology devices.
Automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), pacemakers, and catheters are some of the therapeutic devices. Atrial fibrillation and arrhythmia incidence are rising, cardiac implantable electronic devices are becoming more popular, and healthcare approvals are driving the market for electrophysiology devices.
- For instance, the U.S. FDA granted Abbott clearance for the EnSite X EP System with EnSite omnipolar technology for the treatment of cardiac arrhythmias in January 2022.
- For example, Abbott introduced its sensor-enabled TactiCath Contact Force Ablation Catheter in January 2019. When performing an ablation procedure, the device enables precise imaging of the heart.
During the forecast period, the electrophysiology devices market is expected to grow rapidly due to the increasing prevalence of atrial fibrillation and the introduction of technologically sophisticated solutions.
“Rising Worldwide Prevalence of Cardiovascular Disorders”
Global demand for electrophysiology devices is rising as atrial fibrillation, supraventricular tachycardia, and other heart disorders become more common.
- For instance, the Centers for Disease Control and Prevention (CDC) estimate that 0.5% of the world's population is having atrial fibrillation. Additionally, the disorder affects about 2% of people under the age of 65, whereas it affected about 9% of people over the age of 65 globally.
Another dangerous disorder, ventricular tachycardia, is thought to be the cause of 300,000 fatalities annually in the United States alone. Thus, one of the main factors driving the need for heart surgery devices for monitoring and diagnosis of heart diseases is the rising prevalence of cardiovascular illnesses.
- Nearly half of the American people, according to the American Heart Association, experience cardiovascular disease.
- Additionally, atrial fibrillation (AF), which currently affects more than 16 million individuals in Asia Pacific, is expected to affect 72 million people by the year 2050, according to a report released by Biosense Webster Inc., a subsidiary of Johnson & Johnson Services.
What is Hampering Sales of Electrophysiology Devices?
“Presence of Alternative Technologies and Frequent Product Recalls”
One of the key factors predicted to restrain the growth of the electrophysiology devices market during the forecast period is the frequent product recalls involving equipment used for ablation operations.
- For instance, EP Ablation Cables were recalled by Sterilmed Inc. in May 2017. Before that, Biosense Webster had to recall their Class 2 Lasso NAV Duo Loop eco catheters in 2015 because retraction was problematic.
Sales of electrophysiology devices may be hampered by the high costs of related products and inadequate reimbursement policies. On the other hand, the demand for electrophysiology medical devices may face difficulties due to the accessibility of alternative technologies and the shortage of experienced workers in developing countries.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
How is Demand for Electrophysiology Devices Progressing in the United States?
“Increasing Cases of Heart Failure and Presence of Key Market Players”
The United States currently dominates the North American electrophysiology market due to the existence of established healthcare facilities, technological advancements, increasing cases of arrhythmia and heart failure, and the presence of major market players in the nation. This dominance is predicted to continue throughout the forecast period.
A large number of Americans are obese and are more likely to experience cardiovascular problems at least once in their lifetime, which is predicted to fuel sales of electrophysiology implants.
- For instance, according to the World Obesity Atlas 2022 report, by 2030, nearly two-fifths of women (39.72%) and one in three males (34.41%) are expected to have a BMI below 30 kg/m2.
- For instance, in January 2022, Abbott declared that the EnSite X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform accessible in the United States and throughout Europe and intended to assist doctors in treating abnormal heart rhythms, also known as cardiac arrhythmias better had received approval from the United States Food and Drug Administration.
What are the Common Factors Driving Product Sales Growth in Germany & France?
“Rising Cases of Cardiac Arrhythmias and Presence of Advanced Healthcare Facilities”
Germany has a remarkable healthcare system with the most technologically advanced medical equipment for its electrophysiology labs. More than 30% of hospitals in Germany have EP lab facilities. The potential patient base, state-of-the-art healthcare facilities, cutting-edge interventional techniques, and highly qualified medical staff are propelling the growth of the German electrophysiology market.
In 2019, more than 81% of atrial fibrillation studies in Germany underwent ablation operations, with more than 55% of instances having been detected. Germany dominates the European electrophysiology devices market due to its high diagnosis rate, government lab facilities, awareness of cardiac arrhythmias, and use of electrophysiological techniques.
In France, therapeutic interventions and research in the field of cardiac arrhythmias are advancing. The high incidence rates of cardiac arrhythmias, the significant proportion of cardiac interventional treatments, and France's emphasis on healthcare as a national obligation are all contributing to the country's thriving electrophysiology devices market.
Which are Profitable Markets for Electrophysiology Device Producers in Asia Pacific?
“Rapidly Advancing Medical Sector in China & Japan”
The market in Asia Pacific is anticipated to grow at a rapid rate throughout the anticipated timeframe. The region's expansion is mostly driven by the high proportion of elderly people, rising heart disease risk, and unmet therapeutic needs.
Additionally, it is anticipated that developing healthcare infrastructure, greater patient awareness, and higher healthcare spending in the nations such as China, South Korea, Japan, and India will drive demand for EP systems.
- For instance, Shanghai Microport EP Medtech Co., Ltd. and Stereotaxis, Inc. collaborated in August 2021. According to the terms of the contract, Microport EP is to represent EP in China in the distribution of Robotic Magnetic Navigation technology.
A renowned Japanese inventor and manufacturer of cardiovascular devices, Japan Lifeline (JLL), and Baylis Medical have teamed up to bring cutting-edge electrophysiological treatment solutions.
Category-wise Analysis
For Which Disease Type are Electrophysiology Devices Widely Used?
“Rising Prevalence of Atrial Fibrillation Worldwide”
A majority of the market share is dominated by atrial fibrillation, in terms of indication. It is the most prevalent kind of arrhythmia worldwide and is strongly linked to a high risk of blood clotting and stroke.
- In 2022, the British Heart Association predicted that 1.5 million people in the United Kingdom will have atrial fibrillation. In addition, the nation's undetected atrial fibrillation (AF) affects an estimated 270,000 people 65 and older. The sales of electrophysiology medical devices are boosting due to the rising prevalence of AF.
For arrhythmic patients, cutting-edge smartphone applications have recently been developed that can link them with medical specialists. Additionally, clinical and hospital settings are making efforts to incorporate arrhythmia management into their standard course of care.
- For instance, AFib Integrated Care Clinic, a new clinic for people with atrial fibrillation, has been established by UNC AFib Care Network.
Competitive Landscape
Leading companies in the electrophysiology devices market are Abbott Laboratories, Inc, Biosense Webster, Inc, Biotronik SE & Co. KG, and Boston Scientific Corporation.
Some of the key players in the electrophysiology devices market are strongly concentrating on emerging economies to capture potential opportunities by focusing on local supply chain management. They also manage pricing trends, product standards, and safety regulations according to regional marketing tactics.
New Developments :
- Excellent potential for investors to expand in the region is provided by the untapped developing markets in Asian countries such as India and China. For instance, in India, Medtronic released the Micra AV in June 2021. It is a small, entirely self-contained pacemaker that offers AV block sufferers cutting-edge pacing technology through minimally-invasive procedures.
- Koninklijke Philips N.V. declared in November 2021 that it has acquired Cardiologs, a French company that makes medical technologies. With the use of the company's cloud and AI technology, the acquisition will help Philips grow its cardiac diagnostics and monitoring business.
- February 2022: Medtronic said that Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters, the first and only ablation catheters licensed to treat the rising prevalence of juvenile Atrioventricular Nodal Reentrant Tachycardia, had obtained FDA extended approval (AVNRT).
Key Segments of Electrophysiology Devices Industry Research
-
By Product :
- Electrophysiology Ablation Catheters
- Electrophysiology Diagnostic Catheters
- Electrophysiology Laboratory Devices
- Access Devices
-
By Indication :
- Atrial Fibrillation (AF)
- Atrial Flutter (AFL)
- Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WPW)
- Bradycardia
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Laboratories
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Electrophysiology Devices 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Indication Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Electrophysiology Devices 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Atrial Fibrillation (AF) 6.3.2. Atrial Flutter (AFL) 6.3.3. Atrioventricular Nodal Reentrant Tachycardia (AVNRT) 6.3.4. Wolff-Parkinson-White Syndrome (WPW) 6.3.5. Bradycardia 6.4. Market Attractiveness Analysis By Indication 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product , 2018 to 2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2023 to 2033 7.3.1. Electrophysiology Ablation Catheters 7.3.2. Electrophysiology Diagnostic Catheters 7.3.3. Electrophysiology Laboratory Devices 7.3.4. Access Devices 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Laboratories 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Indication 10.3.3. By Product 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Indication 10.4.3. By Product 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Indication 11.3.3. By Product 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Indication 11.4.3. By Product 11.4.4. By End User 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Indication 12.3.3. By Product 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Indication 12.4.3. By Product 12.4.4. By End User 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Indication 13.3.3. By Product 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Indication 13.4.3. By Product 13.4.4. By End User 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Indication 14.3.3. By Product 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Indication 14.4.3. By Product 14.4.4. By End User 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Indication 15.3.3. By Product 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Indication 15.4.3. By Product 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Abbott Laboratories, Inc. 17.3.1.1. Company Overview 17.3.1.2. Indication overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Biosense Webster, Inc. 17.3.2.1. Company Overview 17.3.2.2. Indication overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Biotronik SE & Co. KG 17.3.3.1. Company Overview 17.3.3.2. Indication overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Boston Scientific Corporation 17.3.4.1. Company Overview 17.3.4.2. Indication overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. CardioFocus, Inc. 17.3.5.1. Company Overview 17.3.5.2. Indication overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Medtronic PLC 17.3.6.1. Company Overview 17.3.6.2. Indication overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. MicroPort Scientific Corporation 17.3.7.1. Company Overview 17.3.7.2. Indication overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Nihon Kohden Corporation 17.3.8.1. Company Overview 17.3.8.2. Indication overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Siemens Healthineers 17.3.9.1. Company Overview 17.3.9.2. Indication overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Stereotaxis, Inc. 17.3.10.1. Company Overview 17.3.10.2. Indication overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 02: Global Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 05: Global Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 07: Global Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 08: Global Market Share and BPS Analysis by Product, 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Product, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Product, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Product, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Product, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Product, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Product, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Product, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated electrophysiology devices market growth rate?
Global demand for electrophysiology devices is expected to increase at a CAGR of 8.5% during the next 10 years.
How big is the electrophysiology devices market?
The global electrophysiology devices market is currently valued at US$ 9.20 billion and is expected to reach US$ 20.80 billion by 2033.
Which is the dominating regional market for electrophysiology devices?
North America is considered to be a lucrative market for electrophysiology device producers.
Which electrophysiology product type is gaining traction?
Worldwide sales of electrophysiology ablation catheters are predicted to increase at a CAGR of 9.5% during the forecast period.
Who are the prominent players in the electrophysiology devices market?
Abbott Laboratories, Inc, Biosense Webster, Inc, Biotronik SE & Co. KG, and Boston Scientific Corporation are key manufacturers of electrophysiology devices.
Electrophysiology Devices Market